Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release

Psychoneuroendocrinology

Volumn 30, Issue 5, 2005, Pages 431-437

  Walsh, Patricia ^a   Spelman, Leona ^b   Sharifi, Neda ^c   Thakore, Jogin H ^b  

^a Kilcock Co   (Ireland)

^b St Vincent's Hospital Ireland   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

Adrenocorticotrpin; Cortisol; Hypothalamic pituitary adrenal axis; Metoclopramide; Schizophrenia; Vasopressin

Indexed keywords

CORTICOTROPIN; DOPAMINE RECEPTOR BLOCKING AGENT; HYDROCORTISONE; METOCLOPRAMIDE; VASOPRESSIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; COVARIANCE; DRUG RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 13844271916     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2004.11.003     Document Type: Article

References (51)

1. A. Abi-Dargham Recent evidence for dopamine abnormalities in schizophrenia Eur. Psychiatry 17 2002 341 347
2. American Psychiatric Association 4th ed. Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Press Washington, DC
3. Andreasen, N.C., 1983. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, The University of Iowa.
4. J. Axelrod, and T.D. Resine Stress hormones: their interaction and regulation Science 224 1984 23 29
5. A. Basta-Kaim, B. Budziszewska, L. Jaworska-Feil, M. Tetich, M. Leskiewicz, M. Kubera, and W. Lason Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner Neuropharmacology 43 2002 1035 1043
6. H. Beckmann, R.E. Lang, and W.F. Gattaz Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and of normal controls Psychoneuroendocrinology 10 1985 187 191
7. S. Boesgaard, C. Hagen, A.N. Andersen, M. Fenger, and E. Eldrup Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women Acta Endocrinol (Copenh) 122 1990 29 36
8. A. Breier, and R.W. Buchanan The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients Life Sci. 51 1992 1527 1534
9. M.S. Brownfield, J. Greathouse, S.A. Lorens, J. Armstrong, J.H. Urban, and L. Van der Kar Neuropharmacological characterization of of serotonergic stimulation of vasopressin secretion in concious rats Neuroendocrinology 47 1988 277 283
10. D.C.E. de Goeji, H. Dijkestra, and F.J.H. Tilders Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor secretion, in the external zone of the median eminence of male rats: relationship to subordinate status Endocrinology 131 1991 847 853
11. D.C.E. de Goeji, R. Binnekade, and F.J.H. Tilders Chronic stress enhances vasopressin, but not coorticotropin-releasing factor secretion during hypoglycaemia Am. J. Physiol. 263 1992 E394 E399
12. I. Elman, L. Sokoloff, C.M. Adler, N. Weisenfeld, and A. Breier Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia Am. J. Psychiatry 155 1998 979 981
13. I. Elman, S. Lukas, S.E. Shoaf, D. Rot, C. Adler, and A. Breier Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia J. Psychopharmacol. 17 2003 317 322
14. S.D. Forman, and D.P. Van Kammen Haloperidol attenuates CRF release in the rat: A micro-dialysis study Biol. Psychiatry 39 1996 590 (abstract)
15. S.D. Forman, G. Bissette, J. Yao, C.B. Nemeroff, and D.P. Van Kammen Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia Schizophrenia Res. 12 1994 43 51
16. S.O. Fredericksen, R. Ekman, C-G. Gottfries, E. Widerlov, and S. Jonsson Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics Acta Psychiatrica Scand. 83 1991 273 277
17. I. Gil-Ad, Z. Dickerman, S. Amdusky, and Z. Laron Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects Psychopharmacology 88 1986 496 499
18. M.B. Goldman, K. Blake, R.C. Marks, D. Hedeker, and D.J. Luchins Association of nonsuppression on the DST with primary polydipsia in chronic schizophrenia Am. J. Psychiatry 150 1993 653 655
19. M.B. Goldman, G.L. Robertson, D.J. Luchins, P. Hedeker, and G.N. Pandey Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia Arch. Gen. Psychiatry 54 1997 443 449
20. G. Guillon, A.M. Trueb, D. Joubert, E. Grazzini, L. Chouinard, M. Cote, M.D. Payet, O. Manzoni, C. Barberis, and N. Gallo-Payet Vasopressin stimulates steroid hormone secretion in human adrenal glands: comparison with angiotensin-II effect Endocrinology 136 1995 1285 1295
21. U. Halbreich, B. Zumoff, J. Kream, and D.K. Fukushima The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolaemia J. Clin. Endocrinol. Metab. 54 1982 1262 1264
22. F. Holsboer The endocrinology of mental disease A. Grossman Clinical Endocrinology 1998 Blackwell Science Oxford 1096 1116
23. W. Hundt, M. Kellner, and K. Wiedemann Neuroendocrine effects of a short-term osmotic stimulus in patients with chronic schizophrenia World J. Biol. Psychiatry 2 2001 27 33
24. L.M.C. Jansen, C.C. Gispen-de Wied, and R.S. Kahn Selective impairments in the stress response in schizophrenic patients Psychopharmacology 149 2000 319 325
25. Y. Kaneda, A. Fujii, and T. Ohmori The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 2002 935 938
26. K.S. Kendler, R.E. Weitzman, and R. Rubin Lack of arginine vasopressin response to central dopamine blockade in normal adults J. Clin. Endocrinol. Metab. 47 1978 204 207
27. R.P. Kraus, M. Hux, and P. Grof Psychotropic drug withdrawal and the dexamethasone suppression test Am. J. Psychiatry 144 1987 82 85
28. A. Kudoh, M. Kudo, H. Ishihara, and A. Matsuki Increased plasma vasopressin and atrial naturetic peptide in chronic schizophrenic patients during abdominal surgery Neurospcyhobiology 37 1998 169 174
29. J.J. Legros, C. Gazotti, T. Carvelli, P. Franchimont, M. Timsit-Berthier, R. von Frenckell, and M. Ansseau Apomorphine stimulation of vasopressin and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenia Psychoneuroendocrinology 17 1992 611 617
30. P. Linkowski, V. Geenan, M. Kerkhofs, J. Mendlewicz, and J.J. Legros Cerebrospinal fluid neurophysins in affective illness and in schizophrenia Eur. Arch. Psychiatry Neurol. Sci. 234 1984 162 165
31. L. Lu, Z. Liu, M. Huang, and Z. Zhang Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes Neurochemistry 84 2003 1378 1386
32. D.J. Luchins, K.W. Nettles, and M.B. Goldman Anterior medial temporal volumes in polydipsic schziophrenic patients with and without hypo-osmolelia: a pilot study Biol. Psychiatry 42 1997 767 770
33. K. Nomura, F. Kurimoto, H. Demura, H. Sakurai, T. Nomura, K. Zibiki, M. Naruse, N. Kanai, and K. Shizume The effects of metoclopramide on plasma vasopressin in man Clin. Endocrinol. 21 1984 117 121
34. G. Norbiato, M. Bevilacqua, E. Chebat, P. Bertora, P. Cavaiani, C. Baruto, S. Fumagalli, and U. Raggi Metoclopramide increases vasopressin secretion J. Clin. Endocrinol. Metab. 63 1986 747 750
35. G. Okugawa, K. Omori, J. Suzukawa, Y. Fujiseki, T. Kinoshita, and C. Inagaki Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones J. Neuroendocrinol. 11 1999 887 895
36. J.E. Overall, and D.R. Gorham The brief psychiatric rating scale Psychol. Rep. 10 1962 799 812
37. C.M. Pariante, A. Makoff, S. Lovestone, S. Feroli, A. Heyden, A.H. Miller, and R.W. Kerwin Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters Br. J. Pharmacol. 134 2001 1335 1343
38. C. Rabadan-Diehl, and G. Aguilera Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C Endocrinology 139 1998 3220 3226
39. M. Rao, B. Strebel, A. Halaris, G. Gross, P. Braunig, and M. Marler Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones and cortisol in schizophrenia Psychiatry Res. 57 1995 21 39
40. A.T. Riggs, M.W. Dysken, S.W. Kim, and J.A. Opsahl A review of disorders of water homeostasis in psychiatric patients Psychosomatics 32 1991 133 148
41. P. Rooke, and P.H. Bayliss A new sensitive radioimmunoassay for plasma arginine vasopressin J. Immunoassay 3 1982 115 131
42. A. Roy, D. Pickar, A. Doran, O. Wolkowitz, W. Gallucci, G. Chrousos, and P. Gold The corticotropin-releasing hormone stimulation test in chronic schizophrenia Am. J. Psychiatry 143 1986 1393 1397
43. M.C.M. Ryan, and J.H. Thakore Physical consequences of schizophrenia Life Sci. 71 2002 239 257
44. M.C.M. Ryan, N. Sharifi, R. Condren, and J.H. Thakore Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia Pyschoneuroendocrinology 29 2004 1065 1070
45. K. Seki, T. Kato, and S. Sekiya Corticotrophin and vasopressin responses to metoclopramide in patients with hypothalamic amenorrhoea Clin. Endocrinol. 46 1997 203 207
46. Statistical Graphics Corporation, 1993. Statgraphics, Version 7.0, New York.
47. E. Van Cauter, P. Linkowski, M. Kerkhofs, P. Hubain, M. L'Hermite-Baleriaux, R. Leclercq, M. Brasseur, G. Copinschi, and J. Mendelwicz Circadian and sleep-related endocrine rhythms in schizophrenia Arch. Gen. Psychiatry 48 1991 348 356
48. K.P. Van Kammen, R.N. Waters, and P. Gold Spinal fluid C. Perris G. Strume B. Jansson Biological Psychiatry 1981 Elselvier North Holland Amsterdam 339 344
49. J.D. Veldhuis, A. Iranmenesh, M.L. Johnson, and G. Lizarralde Twenty four hour rhythmns in plasma concentration of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts J. Clin. Endocrinol. Metab. 71 1990 1616 1623
50. E.D. Weitzman, D. Fukushima, C. Nogeire, H. Roffwarg, T.F. Gallagher, and L. Hellman Twenty four hour patterns of the episodic secretion of cortisol in normal subjects J. Clin. Endocrinol. Metab. 33 1971 14 22
51. L.J. Whalley, J.E. Christie, D.H. Blackwood, J. Bennie, H. Dick, I.M. Blackburn, and G. Fink Disturbed endocrine function in the psychoses I: Disordered homeostasis or disease process? Br. J. Psychiatry 155 1989 455 461